83 FR 40532 - Division of Epidemiology and Disease Prevention; Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service Federal Register Volume 83, Issue 158 (August 15, 2018)
Indian Health Service
Federal Register Volume 83, Issue 158 (August 15, 2018)
| Page Range | 40532-40540 | |
| FR Document | 2018-17564 |
[Federal Register Volume 83, Number 158 (Wednesday, August 15, 2018)] [Notices] [Pages 40532-40540] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-17564] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Division of Epidemiology and Disease Prevention; Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities Announcement Type: Competing Supplement Funding Announcement Number: HHS-2018-IHS-EPI-0001 Catalog of Federal Domestic Assistance Number: 93.231 Key Dates Application Deadline Date: September 12, 2018 Review Date: September 14-18, 2018 Earliest Anticipated Start Date: September 30, 2018 I. Funding Opportunity Description Statutory Authority The Indian Health Service (IHS) Office of Public Health Support, Division of Epidemiology and Disease Prevention (DEDP), is accepting applications for cooperative agreement for competitive supplemental funds to enhance activities in the Epidemiology Program for American Indian/Alaska Native (AI/AN) Tribes and Urban Indian communities. This program is authorized under: Section 317(k)(2) of the Public Health Service Act (42 U.S.C. Section 247b(k)), as amended. Funding for this award will be provided by: The Centers for Disease Control and Prevention's (CDC) National Center for Chronic Disease Prevention and Health Promotion. The authorities will be exercised by CDC and through an Intra-Departmental Delegation of Authority [[Page 40533]] (IDDA) with IHS to create a supplemental funding opportunity for Tribal Epidemiology Centers. The administration will be carried out through an Intra-agency Agreement (IAA) between CDC and IHS. This program is described in the Catalog of Federal Domestic Assistance (CFDA) under 93.231. Background The Tribal Epidemiology Center (TEC) program was authorized by Congress in 1998 as a way to provide public health support to multiple Tribes and Urban Indian communities in each of the IHS Areas. Only current TEC grantees are eligible to apply for the competing supplemental funding under this announcement and must demonstrate that they have complied with previous terms and conditions of the TEC program. TECs are uniquely positioned within Tribes, Tribal and Urban Indian organizations to conduct disease surveillance, research, prevention and control of disease, injury, or disability, and to assess the effectiveness of AI/AN public health programs. Positioned uniquely within Tribes and Tribal or Urban Organizations, TECs are able to conduct disease surveillance, research, prevention and control of disease, injury, or disability. This allows them to assess the effectiveness of AI/AN public health programs. In addition, they can fill gaps in data needed for the relevant Government Performance and Results Act and Healthy People 2020 measures. Some of the existing TECs have already developed innovative strategies to monitor the health status of Tribes and Urban Indian communities, including the development of Tribal health registries and use of sophisticated record linkage computer software to correct existing state data sets for racial misclassification. Tribal Epidemiology Centers work in partnership with IHS DEDP to provide a more accurate national picture of Indian health status. To further the goals of the partnership, a new CDC funding opportunity will be made available to TECs to implement cancer projects in Indian Country, designed to help decrease these disparities and lessen the burden of cancer in this population. For administrative purposes, this new funding opportunity will be packaged with the existing IHS cooperative agreements. The mission of the CDC National Center for Chronic Disease Prevention and Health Promotion is to help people and communities prevent chronic diseases and promote health and wellness for all. Within the National Center for Chronic Disease Prevention and Health Promotion, the Division of Cancer Prevention and Control (DCPC) works with national organizations, state and Tribal health agencies, and other key groups to develop, implement, and promote effective strategies for preventing and controlling cancer. Purpose The National Center for Chronic Disease Prevention and Health Promotion will be supporting two activities with funding from DCPC. The first, Colorectal Cancer Screening Among AI/AN with Diabetes, seeks to reduce a diabetes-linked cancer health disparity experienced by the AI/ AN population. This population experiences the highest rates of diabetes in the United States. Despite the recent identification of diabetes as a significant risk factor for colorectal cancer (CRC), screening rates remain poor in the diabetic population. Consequently, there is a critical need for effective intervention that promotes both CRC risk awareness and screening among AI/ANs with diabetes. The second National Center for Chronic Disease Prevention and Health Promotion activity, Annual Cancer Survivorship Group Leadership Training, seeks to increase cancer survivor support group leadership in AI/AN communities. This cooperative agreement is to support the following National Center for Chronic Disease Prevention and Health Promotion activities: (a) Colorectal Cancer Screening Among AI/AN with Diabetes. i. Develop a culturally grounded, multilevel intervention to communicate CRC risk and prevention information to AI/AN men and women over age 50 who have diabetes. ii. Determine effectiveness of colorectal cancer screening through direct mailing fecal immunochemical test (FIT) kits to AI/AN patients with diabetes. iii. Develop a plan to embed CRC control initiatives within established diabetes management systems at Indian Health Service/Tribal health facilities. (b) Annual Cancer Survivorship Leadership Training. i. Organize and implement at least two, three-day cancer support leadership trainings for 15-25 AI/AN participants, nationally. The training will be designed to give participants a unique opportunity to work together in a safe, supportive environment to learn and practice skills to help people affected by cancer in their communities. The training will be based on the model, A Gathering of Cancer Support, using the Gathering of Native Americans (GONA) teaching methods. Limited Competition Justification The IHS enters into cooperative agreements with TECs under the authority of Section 214(a)(1) of the Indian Health Care Improvement Act, Public Law 94-437, as amended by Public Law 102-573. Tribal Epidemiology Centers carry out a list of functions specified in statute. These functions include data collection and analysis; evaluation of existing delivery systems, data systems, and other systems that impact the improvement of Indian health; making recommendations for the targeting of services; and provision of requested technical assistance to Indian Tribes, Tribal organizations, and Urban Indian organizations [25 U.S.C. 1621m(b)]. Other organizations do not have the capacity to provide this support. With respect to access to information, TECs are treated as public health authorities for the purposes of the Health Insurance Portability and Accountability Act of 1996 (Pub L. 104-191). Unlike their counterparts, they have no (or little) funding from their jurisdictional governments to perform these public functions. The IHS and the CDC have determined that the TECs provide the most effective approach to strengthen public health capacity to support Tribes, Tribal organizations, and Urban Indian organizations, in identifying relevant health status indicators and priorities using sound epidemiologic principles. II. Award Information Type of Award Cooperative Agreement. Estimated Funds Available The total amount of funding identified for the current fiscal year (FY) 2018 is approximately $220,000. An estimated $135,000 will be awarded for the National Center for Chronic Disease Prevention and Health Promotion Colorectal Cancer Screening Among American Indians with Diabetes activities, and, a total of $85,000 will be awarded for the National Center for Chronic Disease Prevention and Health Promotion Annual Cancer Survivorship Group Leadership Trainings. Individual award amounts are anticipated to be between $85,000 and $220,000. The amount of funding available for competing and continuation awards issued under this announcement are subject to the availability of appropriations and budgetary priorities of the CDC. The IHS is under no [[Page 40534]] obligation to make awards that are selected for funding under this announcement. Anticipated Number of Awards Approximately two awards will be issued under this program announcement. Period of Performance The period of performance is for three years and will run consecutively from September 30, 2018 to September 29, 2021. Cooperative Agreement Cooperative agreements awarded by the Department of Health and Human Services (HHS) are administered under the same policies as a grant. However, the funding agency (CDC) is required to have substantial programmatic involvement in the project during the entire award segment. Below is a detailed description of the level of involvement required for both the CDC and the grantee. The CDC, per the MOU between the IHS and the CDC, will be responsible for activities listed under section A and the grantee will be responsible for activities listed under section B as stated: Substantial Involvement Description for Cooperative Agreement A. CDC Programmatic Involvement (1) Provide funded TECs with ongoing consultation and technical assistance to plan, implement, and evaluate each component as described under Recipient Activities. Consultation and technical assistance may include, but not be limited to, the following areas: (i) Interpretation of current scientific literature related to epidemiology, statistics, surveillance, and other public health issues; (ii) Technical Assistance on the design and implementation of each program component such as surveillance, epidemiologic analysis, outbreak investigation, development of epidemiologic studies, development of disease control programs, and coordination of activities; and (iii) Technical Assistance on overall operational planning and program management. (2) Conduct routine site visits to TECs and/or coordinate TEC visits to IHS headquarters in order to assess work plans and ensure data security, confirm compliance with applicable laws and regulations, assess program activities, and to mutually resolve problems, as needed. B. Grantee Cooperative Agreement Award Activities (1) Provide a work plan to accomplish tasks described under National Center for Chronic Disease Prevention and Health Promotion Activities in the Purpose section. (2) Succinctly and independently address and report on the requirements for each funding stream awarded under Recipient Activities. Specifically: (i) Colorectal Cancer Screening Among American Indians with Diabetes. (a) Submit documentation of approval for the study/project from all necessary Institutional Review Boards (IRBs) including IHS, CDC, and Tribal (if applicable) prior to initiation of any study involving human subjects. (b) Coordinate testing of an innovative, multilevel intervention to promote fecal immunochemical testing (FIT) among American Indian men and women of or over age 50 who have diabetes. (c) Coordinate testing of the intervention model for feasibility and effectiveness to be carried out by four Tribal health programs, should such programs agree to participate. (ii) Annual Cancer Survivorship Group Leadership Training. (a) Work plan must include the training objectives, trainers, and the utilization of GONA training methods. The work plan must include an outline of outreach efforts to Tribal communities across the United States, not just with the TEC's catchment area. The following should also be considered when planning the training:Based on a grassroots approach, an order of preference for Tribal community members attending the training would be cancer survivors, family members of cancer survivors, Tribal health care workers, and others. The selection will be further based on the intention of the attendee and their plans for use of the training in their community. To establish cancer support services in the Tribal community, it is suggested that two people from the same community attend the training together to assist each other in the future. To reach as many Tribal communities and members as possible, each training should be limited to new participants. Submit report describing the number of trainings that were conducted and how many participants attended each training. Submit registration forms of attendees and their contact information for use in updating list of previous attendees. III. Eligibility Information 1. Eligibility Only current TEC grantees are eligible to apply for the competing supplemental funding under this announcement and must demonstrate that they have complied with previous terms and conditions of the TEC program. Note: Please refer to Section IV.2 (Application and Submission Information/Subsection 2, Content and Form of Application Submission) for additional proof of applicant status documents required, such as proof of non-profit status, etc. 2. Cost Sharing or Matching The IHS does not require matching funds or cost sharing for grants or cooperative agreements. 3. Other Requirements If application budgets exceed the highest dollar amount outlined under the Estimated Funds Available section within this funding announcement, the application will be considered ineligible and will not be reviewed for further consideration. If deemed ineligible, IHS will not return the application. The applicant will be notified by email by the Division of Grants Management (DGM) of this decision. IV. Application and Submission Information 1. Obtaining Application Materials The application package and detailed instructions for this announcement can be found at http://www.Grants.gov or http://www.ihs.gov/dgm/funding/. Questions regarding the electronic application process may be directed to Mr. Paul Gettys at (301) 443-2114 or (301) 443-5204. 2. Content and Form Application Submission The applicant must include the project narrative as an attachment to the application package. Mandatory documents for all applicants include: Table of contents. Abstract (one page) summarizing the project. Application forms: [cir] SF-424, Application for Federal Assistance. [cir] SF-424A, Budget Information--Non-Construction Programs. [cir] SF-424B, Assurances--Non-Construction Programs. Budget Justification and Narrative (must be single-spaced and not exceed 5 pages). Project Narrative (must be single-spaced and not exceed 10 pages). [[Page 40535]] [cir] Background information on the organization. [cir] Proposed scope of work, objectives, and activities that provide a description of what will be accomplished, including a one- page Timeframe Chart. Letters of Support from organization's Board of Directors. 501(c)(3) Certificate (if applicable). Biographical sketches for all Key Personnel. Contractor or Consultant resumes or qualifications and scope of work. Disclosure of Lobbying Activities (SF-LLL). Certification Regarding Lobbying (GG-Lobbying Form). Copy of current Negotiated Indirect Cost rate (IDC) agreement (required in order to receive IDC). Organizational Chart (optional). Documentation of current Office of Management and Budget (OMB) Financial Audit (if applicable). Acceptable forms of documentation include: [cir] Email confirmation from Federal Audit Clearinghouse (FAC) that audits were submitted; or [cir] Face sheets from audit reports. These can be found on the FAC website: https://harvester.census.gov/facdissem/Main.aspx. Public Policy Requirements All Federal-wide public policies apply to IHS grants and cooperative agreements with exception of the Discrimination policy. Requirements for Project and Budget Narratives A. Project Narrative: This narrative should be a separate Word document that is no longer than 10 pages and must: Be single-spaced, type written, have consecutively numbered pages, use black type not smaller than 12 points, and be printed on one side only of standard size 8\1/2\'' x 11'' paper. Be sure to succinctly answer all questions listed under the evaluation criteria (refer to Section V.1, Evaluation criteria in this announcement) and place all responses and required information in the correct section (noted below), or they will not be considered or scored. These narratives will assist the Objective Review Committee (ORC) in becoming familiar with the applicant's activities and accomplishments prior to this possible cooperative agreement award. If the narrative exceeds the page limit, only the first 10 pages will be reviewed. The 10-page limit for the narrative does not include the work plan, standard forms, table of contents, budget, budget justifications, narratives, and/or other appendix items. There are three parts to the narrative: Part A--Program Information; Part B--Program Planning and Evaluation; and Part C-- Program Report. See below for additional details about what must be included in the narrative. The page limitations below are for each narrative and budget submitted. Part A: Program Information (3 Pages) Section 1: Introduction and Need for Assistance Must include the applicant's background information, a description of epidemiological service, epidemiological capacity and history of support for such activities. Applicants need to include current public health activities, what program services are currently being provided, and interactions with other public health authorities in the region (state, local, or Tribal). Section 2: Organizational Capabilities The applicant must describe staff capabilities or hiring plans for the key personnel with appropriate expertise in epidemiology, health sciences, and program management. The applicant must also demonstrate access to specialized expertise such as a doctoral level epidemiologist and/or a biostatistician. Applicants must include an organizational chart, and provide position descriptions and biographical sketches of key personnel including consultants or contractors. The position description should clearly describe each position and its duties. Resume should indicate that proposed staff is qualified to carry out the project activities. Section 3: User Population The number of AI/ANs served must be substantiated by documentation describing IHS user populations, United States Census Bureau data, clinical catchment data, or any method that is scientifically and epidemiologically valid. Part B: Program Planning and Evaluation (5 Pages) Section 1: Program Plans Applicant must include a workplan that describes program goals, objectives, activities, timeline, and responsible person for carrying out the objectives/activities. The applicant must specify which activities listed under the Grantee Cooperative Agreement Award Activities are proposed. Section 2: Program Evaluation Applicant must define the criteria to be used to evaluate activities listed in the workplan under the Grantee Cooperative Agreement Award Activities. They must explain the methodology that will be used to determine if the needs identified for the objectives are being met and if the outcomes identified are being achieved and describe how evaluation findings will be disseminated to stakeholders. Part C: Program Report (2 Pages) Section 1: Describe your organization's significant program activities and accomplishments over the past five years associated with the goals of this announcement. Section 2: Describe major activities over the last 24 months related to conducting applied research projects, training community health representatives, implementing quality improvement initiatives in IHS or Tribal healthcare facilities, and/or organizing cancer survivor group leadership trainings. B. Budget Narrative (5 Pages) This narrative must include a line item budget with a narrative justification for all expenditures identifying reasonable allowable, allocable costs necessary to accomplish the goals and objectives as outlined in the project narrative. Budget should match the scope of work described in the project narrative. 3. Submission Dates and Times Applications must be submitted electronically through Grants.gov by 11:59 p.m. Eastern Daylight Time (EDT) on the Application Deadline Date listed in the Key Dates section on page one of this announcement. Any application received after the application deadline will not be accepted for processing, nor will it be given further consideration for funding. Grants.gov will notify the applicant via email if the application is rejected. If technical challenges arise and assistance is required with the electronic application process, contact Grants.gov Customer Support via email to [email protected] or at (800) 518-4726. Customer Support is available to address questions 24 hours a day, 7 days a week (except on Federal holidays). If problems persist, contact Mr. Gettys ([email protected]), DGM Grant Systems Coordinator, by telephone at (301) 443-2114 or (301) 443-5204. Please contact Mr. Gettys at least ten days prior to the application deadline. Please do not contact the DGM until you have received a Grants.gov tracking number. In the event you are not able to obtain a tracking number, call the DGM as soon as possible. [[Page 40536]] 4. Intergovernmental Review Executive Order 12372 requiring intergovernmental review is not applicable to this program. 5. Funding Restrictions Pre-award costs are not allowable. The available funds are inclusive of direct and appropriate indirect costs. Only one grant/cooperative agreement will be awarded per applicant. IHS will not acknowledge receipt of applications. 6. Electronic Submission Requirements All applications must be submitted electronically. Please use the http://www.Grants.gov website to submit an application electronically and select the ``Search Grants'' link on the homepage. Follow the instructions for submitting an application under the Package tab. Electronic copies of the application may not be submitted as attachments to email messages addressed to IHS employees or offices. Waiver Request If the applicant needs to submit a paper application instead of submitting electronically through Grants.gov, a waiver must be requested. Prior approval must be requested and obtained from Mr. Robert Tarwater, Director, DGM, (see Section IV.6 below for additional information). A written waiver request must be sent to [email protected] with a copy to [email protected]. The waiver must: (1) Be documented in writing (emails are acceptable), before submitting a paper application, and (2) include clear justification for the need to deviate from the required electronic grants submission process. Once the waiver request has been approved, the applicant will receive a confirmation of approval email containing submission instructions and the mailing address to submit the application. A copy of the written approval must be submitted along with the hardcopy of the application that is mailed to DGM. Paper applications that are submitted without a copy of the signed waiver from the Director of the DGM will not be reviewed or considered for funding. The applicant will be notified via email of this decision by the Grants Management Officer of the DGM. Paper applications must be received by the DGM no later than 5:00 p.m., EDT, on the Application Deadline Date listed in the Key Dates section on page one of this announcement. Late applications will not be accepted for processing or considered for funding. Applicants that do not adhere to the timelines for System for Award Management (SAM) and/or http://www.Grants.gov registration or that fail to request timely assistance with technical issues will not be considered for a waiver to submit a paper application. Please be aware of the following: Please search for the application package in http://www.Grants.gov by entering the CFDA number or the Funding Opportunity Number. Both numbers are located in the header of this announcement. If you experience technical challenges while submitting your application electronically, please contact Grants.gov Support directly at: [email protected] or (800) 518-4726. Customer Support is available to address questions 24 hours a day, 7 days a week (except on Federal holidays). Upon contacting Grants.gov, obtain a tracking number as proof of contact. The tracking number is helpful if there are technical issues that cannot be resolved and a waiver from the agency must be obtained. Applicants are strongly encouraged not to wait until the deadline date to begin the application process through Grants.gov as the registration process for SAM and Grants.gov could take up to fifteen working days. Please use the optional attachment feature in Grants.gov to attach additional documentation that may be requested by the DGM. All applicants must comply with any page limitation requirements described in this funding announcement. After electronically submitting the application, the applicant will receive an automatic acknowledgment from Grants.gov that contains a Grants.gov tracking number. The DGM will download the application from Grants.gov and provide necessary copies to the appropriate agency officials. Neither the DGM nor the Division of Epidemiology and Disease Prevention will notify the applicant that the application has been received. Email applications will not be accepted under this announcement. Dun and Bradstreet (D&B) Data Universal Numbering System (DUNS) All IHS applicants and grantee organizations are required to obtain a DUNS number and maintain an active registration in the SAM database. The DUNS number is a unique 9-digit identification number provided by D&B which uniquely identifies each entity. The DUNS number is site specific; therefore, each distinct performance site may be assigned a DUNS number. Obtaining a DUNS number is easy, and there is no charge. To obtain a DUNS number, you may access it through http://fedgov.dnb.com/webform, or to expedite the process, call (866) 705- 5711. All HHS recipients are required by the Federal Funding Accountability and Transparency Act of 2006, as amended (``Transparency Act''), to report information on sub-awards. Accordingly, all IHS grantees must notify potential first-tier sub-recipients that no entity may receive a first-tier sub-award unless the entity has provided its DUNS number to the prime grantee organization. This requirement ensures the use of a universal identifier to enhance the quality of information available to the public pursuant to the Transparency Act. System for Award Management (SAM) Organizations that were not registered with Central Contractor Registration and have not registered with SAM will need to obtain a DUNS number first and then access the SAM online registration through the SAM home page at https://www.sam.gov (U.S. organizations will also need to provide an Employer Identification Number from the Internal Revenue Service that may take an additional 2-5 weeks to become active). Completing and submitting the registration takes approximately one hour to complete and SAM registration will take 3-5 business days to process. Registration with the SAM is free of charge. Applicants may register online at https://www.sam.gov. Additional information on implementing the Transparency Act, including the specific requirements for DUNS and SAM, can be found on the IHS Grants Management, Grants Policy website: http://www.ihs.gov/dgm/policytopics/. V. Application Review Information The instructions for preparing the application narrative also constitute the evaluation criteria for reviewing and scoring the application. Weights assigned to each section are noted in parentheses. The 10 page narrative should include only the first year of activities; information for multi-year projects should be included as an appendix. See ``Multi-year Project Requirements'' at the end of this section for more information. The narrative section should be written in a manner that is clear to outside reviewers unfamiliar with prior related activities of the applicant. It should be well organized, succinct, and contain all information necessary for reviewers to understand the project fully. Points will be assigned to each evaluation criteria [[Page 40537]] adding up to a total of 100 points. A minimum score of 65 points is required for funding. Points are assigned as follows: 1. Criteria A. Introduction and Need for Assistance (25 Points) (1) Describe the applicant's current public health activities, including programs or services currently provided, interactions with other public health authorities in the regions (state, local, or Tribal) and how long the organization has been operating. Specifically describe the organization's current capacity to conduct applied research projects, train community health representatives, implement quality improvement initiatives, and/or organize cancer survivor group leadership trainings and provide examples of implementing these activities. (2) Provide a physical location of the TEC and area to be served by the proposed program including a map (include the map in the attachments), and specifically describe the office space and how it is going to be paid for. (3) Describe the applicant's user population. The applicant must demonstrate AI/ANs will be served and must be substantiated by documentation describing IHS user populations, United States Census Bureau data, clinical catchment data, or any method that is scientifically and epidemiologically valid. B. Project Objective(s), Work Plan and Approach (45 Points) (1) State in measurable and realistic terms the objectives and appropriate activities to achieve each objective for the projects under the Substantial Involvement Description for Cooperative Agreement, Section B. Grantee Cooperative Agreement Award Activities located on page 8. (2) Identify the expected results, benefits, and outcomes or products to be derived from each objective of the project. (3) Include a work-plan for each objective that indicates when the objectives and major activities will be accomplished and who will conduct the activities. C. Program Evaluation (10 Points) (1) Define the criteria to be used to evaluate activities listed in the work-plan under the Substantial Involvement Description for Cooperative Agreement, Section B. Grantee Cooperative Agreement Award Activities located on page 8. (2) Explain the methodology that will be used to determine if the needs identified for the objectives are being met and if the outcomes identified are being achieved. (3) Describe how evaluation findings will be disseminated to stakeholders, including the Indian Health Service. D. Organizational Capabilities, Key Personnel and Qualifications (15 Points) (1) Explain both the management and administrative structure of the organization including documentation of current certified financial management systems from the Bureau of Indian Affairs, IHS, or a Certified Public Accountant and an updated organizational chart (include in appendix). (2) Describe the ability of the organization to manage a program of the proposed scope. (3) Provide position descriptions and biographical sketches of key personnel, including those of consultants or contractors in the Appendix. Position descriptions should very clearly describe each position and its duties, indicating desired qualification and experience requirements related to the project. Resumes should indicate that the proposed staff is qualified to carry out the project activities. Applicants with expertise in epidemiology will receive priority. E. Categorical Budget and Budget Justification (5 Points) (1) The five points for Categorical Budget only applies to Year 1. Provide a line item budget and budget narrative for Year 1. (2) Provide a justification by line item in the budget including sufficient cost and other details to facilitate the determination of cost allowance and relevance of these costs to the proposed project. The funds requested should be appropriate and necessary for the scope of the project. (3) If use of consultants or contractors are proposed or anticipated, provide a detailed budget and scope of work that clearly defines the deliverables or outcomes anticipated. (4) Applicant is encouraged to submit a line item budget and budget narrative by category for years 2-3 as an appendix to show the three- year plan of the proposal. Multi-Year Project Requirements Projects requiring a second, or third year must include a brief project narrative and budget (one additional page per year) addressing the developmental plans for each additional year of the project. Additional Documents Can be Uploaded as Appendix Items in Grants.gov Work plan, logic model and/or time line for proposed objectives. Position descriptions for key staff. Resumes of key staff that reflect current duties. Consultant or contractor proposed scope of work and letter of commitment (if applicable). Current Indirect Cost Agreement. Organizational chart. Map of area identifying project location(s). Additional documents to support narrative (i.e., data tables, key news articles, etc.). 2. Review and Selection Each application will be prescreened by the DGM staff for eligibility and completeness as outlined in the funding announcement. Applications that meet the eligibility criteria shall be reviewed for merit by the ORC based on evaluation criteria in this funding announcement. The ORC could be composed of both Tribal and Federal reviewers appointed by the IHS Program to review and make recommendations on these applications. The technical review process ensures selection of quality projects in a national competition for limited funding. Incomplete applications and applications that are non- responsive to the eligibility criteria will not be referred to the ORC. The applicant will be notified via email of this decision by the Grants Management Officer of the DGM. Applicants will be notified by DGM, via email, regarding minor missing components (i.e., budget narratives, audit documentation, key contact form) needed for an otherwise complete application. All missing documents must be sent to DGM on or before the due date listed in the email of notification of missing documents required. To obtain a minimum score for funding by the ORC, applicants must address all program requirements and provide all required documentation. VI. Award Administration Information 1. Award Notices The Notice of Award (NoA) is a legally binding document signed by the Grants Management Officer and serves as the official notification of the grant award. The NoA will be initiated by the DGM in our grant system, GrantSolutions (https://www.grantsolutions.gov). Each entity that is approved for funding under this announcement will need to request or have a user account in GrantSolutions [[Page 40538]] in order to retrieve their NoA. The NoA is the authorizing document for which funds are dispersed to the approved entities and reflects the amount of Federal funds awarded, the purpose of the grant, the terms and conditions of the award, the effective date of the award, and the budget and project period. Disapproved Applicants Applicants who received a score less than the recommended funding level for approval, 65, and were deemed to be disapproved by the ORC, will receive an Executive Summary Statement from the IHS program office within 30 days of the conclusion of the ORC outlining the strengths and weaknesses of their application. The summary statement will be sent to the Authorized Organizational Representative that is identified on the face page (SF-424) of the application. The IHS program office will also provide additional contact information as needed to address questions and concerns as well as provide technical assistance if desired. Approved But Unfunded Applicants Approved but unfunded applicants that met the minimum scoring range and were deemed by the ORC to be ``Approved,'' but were not funded due to lack of funding, will have their applications retained by DGM for a period of one year. If additional funding becomes available during the course of FY 2018 the approved but unfunded application may be re- considered by the awarding program office for possible funding. The applicant will also receive an Executive Summary Statement from the IHS program office within 30 days of the conclusion of the ORC. Note: Any correspondence other than the official NoA signed by an IHS grants management official announcing to the project director that an award has been made to their organization is not an authorization to implement their program on behalf of IHS. 2. Administrative Requirements Cooperative agreements are administered in accordance with the following regulations and policies: A. The criteria as outlined in this program announcement. B. Administrative Regulations for Grants: Uniform Administrative Requirements for HHS Awards, located at 45 CFR part 75. C. Grants Policy: HHS Grants Policy Statement, Revised 01/07. D. Cost Principles: Uniform Administrative Requirements for HHS Awards, ``Cost Principles,'' located at 45 CFR part 75, subpart E. E. Audit Requirements: Uniform Administrative Requirements for HHS Awards, ``Audit Requirements,'' located at 45 CFR part 75, subpart F. 3. Indirect Costs This section applies to all grant recipients that request reimbursement of indirect costs (IDC) in their grant application. In accordance with HHS Grants Policy Statement, Part II-27, IHS requires applicants to obtain a current IDC rate agreement prior to award. The rate agreement must be prepared in accordance with the applicable cost principles and guidance as provided by the cognizant agency or office. A current rate covers the applicable grant activities under the current award's budget period. If the current rate is not on file with the DGM at the time of award, the IDC portion of the budget will be restricted. The restrictions remain in place until the current rate is provided to the DGM. Generally, IDC rates for IHS grantees are negotiated with the Division of Cost Allocation (DCA) https://rates.psc.gov/ and the Department of Interior (Interior Business Center) https://www.doi.gov/ibc/services/finance/indirect-Cost-Services/indian-tribes. For questions regarding the indirect cost policy, please call the Grants Management Specialist listed under ``Agency Contacts'' or the main DGM office at (301) 443-5204. 4. Reporting Requirements The grantee must submit required reports consistent with the applicable deadlines. Failure to submit required reports within the time allowed may result in suspension or termination of an active grant, withholding of additional awards for the project, or other enforcement actions such as withholding of payments or converting to the reimbursement method of payment. Continued failure to submit required reports may result in one or both of the following: (1) The imposition of special award provisions; and (2) the non-funding or non- award of other eligible projects or activities. This requirement applies whether the delinquency is attributable to the failure of the grantee organization or the individual responsible for preparation of the reports. Per DGM policy, all reports are required to be submitted electronically by attaching them as a ``Grant Note'' in GrantSolutions. Personnel responsible for submitting reports will be required to obtain a login and password for GrantSolutions. Please see the Agency Contacts list in Section VII for the systems contact information. The reporting requirements for this program are noted below. A. Progress Reports Program progress reports are required annually, within 30 days after the budget period ends. These reports must include a brief comparison of actual accomplishments to the goals established for the period, a summary of progress to date or, if applicable, provide sound justification for the lack of progress, and other pertinent information as required. A final report must be submitted within 90 days of the expiration of the period of performance. B. Financial Reports Federal Financial Report (FFR or SF-425), Cash Transaction Reports are due 30 days after the close of every calendar quarter to the Payment Management Services, HHS at https://pms.psc.gov. It is recommended that the applicant also send a copy of the FFR (SF-425) report to the Grants Management Specialist. Failure to submit timely reports may cause a disruption in timely payments to the organization. Grantees are responsible and accountable for accurate information being reported on all required reports: The Progress Reports and Federal Financial Report. C. Federal Sub-Award Reporting System (FSRS) This award may be subject to the Transparency Act sub-award and executive compensation reporting requirements of 2 CFR part 170. The Transparency Act requires the OMB to establish a single searchable database, accessible to the public, with information on financial assistance awards made by Federal agencies. The Transparency Act also includes a requirement for recipients of Federal grants to report information about first-tier sub-awards and executive compensation under Federal assistance awards. IHS has implemented a Term of Award into all IHS Standard Terms and Conditions, NoAs and funding announcements regarding the FSRS reporting requirement. This IHS Term of Award is applicable to all IHS grant and cooperative agreements issued on or after October 1, 2010, with a $25,000 sub-award obligation dollar threshold met for any specific reporting period. Additionally, all new (discretionary) IHS awards (where the period of performance is made up of more than one budget period) and where: (1) The period of performance start date was [[Page 40539]] October 1, 2010 or after, and (2) the primary awardee will have a $25,000 sub-award obligation dollar threshold during any specific reporting period will be required to address the FSRS reporting. For the full IHS award term implementing this requirement and additional award applicability information, visit the DGM Grants Policy website at http://www.ihs.gov/dgm/policytopics/. D. Compliance With Executive Order 13166 Implementation of Services Accessibility Provisions for All Grant Application Packages and Funding Opportunity Announcements Recipients of Federal financial assistance (FFA) from HHS must administer their programs in compliance with Federal civil rights law. This means that recipients of HHS funds must ensure equal access to their programs without regard to a person's race, color, national origin, disability, age and, in some circumstances, sex and religion. This includes ensuring your programs are accessible to persons with limited English proficiency. HHS provides guidance to recipients of FFA on meeting their legal obligation to take reasonable steps to provide meaningful access to their programs by persons with limited English proficiency. Please see http://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/guidance-federal-financial-assistance-recipients-title-VI/. The HHS Office for Civil Rights (OCR) also provides guidance on complying with civil rights laws enforced by HHS. Please see http://www.hhs.gov/civil-rights/for-individuals/section-1557/index.html; and http://www.hhs.gov/civil-rights/index.html. Recipients of FFA also have specific legal obligations for serving qualified individuals with disabilities. Please see http://www.hhs.gov/civil-rights/for-individuals/disability/index.html. Please contact the HHS OCR for more information about obligations and prohibitions under Federal civil rights laws at https://www.hhs.gov/ocr/about-us/contact-us/index.html or call (800) 368-1019 or TDD (800) 537-7697. Also note it is an HHS Departmental goal to ensure access to quality, culturally competent care, including long-term services and supports, for vulnerable populations. For further guidance on providing culturally and linguistically appropriate services, recipients should review the National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care at https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=2&lvlid=53. Pursuant to 45 CFR 80.3(d), an individual shall not be deemed subjected to discrimination by reason of his or her exclusion from benefits limited by Federal law to individuals eligible for benefits and services from the IHS. Recipients will be required to sign the HHS- 690 Assurance of Compliance form which can be obtained from the following website: http://www.hhs.gov/sites/default/files/forms/hhs-690.pdf, and send it directly to the: U.S. Department of Health and Human Services, Office of Civil Rights, 200 Independence Ave. SW, Washington, DC 20201. E. Federal Awardee Performance and Integrity Information System (FAPIIS) The IHS is required to review and consider any information about the applicant that is in the Federal Awardee Performance and Integrity Information System (FAPIIS) before making any award in excess of the simplified acquisition threshold (currently $150,000) over the period of performance. An applicant may review and comment on any information about itself that a Federal awarding agency previously entered. IHS will consider any comments by the applicant, in addition to other information in FAPIIS in making a judgment about the applicant's integrity, business ethics, and record of performance under Federal awards when completing the review of risk posed by applicants as described in 45 CFR 75.205. As required by 45 CFR part 75 Appendix XII of the Uniform Guidance, non-federal entities (NFEs) are required to disclose in FAPIIS any information about criminal, civil, and administrative proceedings, and/ or affirm that there is no new information to provide. This applies to NFEs that receive Federal awards (currently active grants, cooperative agreements, and procurement contracts) greater than $10,000,000 for any period of time during the period of performance of an award/project. Mandatory Disclosure Requirements As required by 2 CFR part 200 of the Uniform Guidance, and the HHS implementing regulations at 45 CFR part 75, effective January 1, 2016, the IHS must require a non-Federal entity or an applicant for a Federal award to disclose, in a timely manner, in writing to the IHS or pass- through entity all violations of Federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the Federal award. Submission is required for all applicants and recipients, in writing, to the IHS and to the HHS Office of Inspector General all information related to violations of Federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the Federal award. 45 CFR 75.113. Disclosures must be sent in writing to: U.S. Department of Health and Human Services, Indian Health Service, Division of Grants Management, Attn: Robert Tarwater, Director, 5600 Fishers Lane, Mail Stop: 09E70, Rockville, MD 20857, (Include ``Mandatory Grant Disclosures'' in subject line). Office: (301) 443-5204, Fax: (301) 594- 0899, Email: [email protected] AND U.S. Department of Health and Human Services, Office of Inspector General, Attn: Mandatory Grant Disclosures, Intake Coordinator, 330 Independence Avenue SW, Cohen Building, Room 5527, Washington, DC 20201, URL: http://oig.hhs.gov/fraud/report-fraud/index.asp (Include ``Mandatory Grant Disclosures'' in subject line). Fax: (202) 205-0604 (Include ``Mandatory Grant Disclosures'' in subject line) or Email: [email protected]. Failure to make required disclosures can result in any of the remedies described in 45 CFR 75.371. Remedies for noncompliance, including suspension or debarment (See 2 CFR parts 180 and 376 and 31 U.S.C. 3321). VII. Agency Contacts 1. Questions on the programmatic issues may be directed to: Lisa C. Neel, Public Health Advisor, Office of Public Health Support, Division of Epidemiology & Disease Prevention, Indian Health Service, 5600 Fishers Lane, Mailstop: 09E17B, Rockville, MD 20857, Phone: (301) 443- 4305, Email: [email protected]. 2. Questions on grants management and fiscal matters may be directed to: John Hoffman, Senior Grants Management Specialist, 5600 Fishers Lane, Mail Stop: 09E70, Rockville, MD 20857, Phone: (301) 443- 2116, Fax: (301) 594-0899, Email: [email protected]. 3. Questions on systems matters may be directed to: Paul Gettys, Grant Systems Coordinator, 5600 Fishers Lane, Mail Stop: 09E70, Rockville, MD 20857, Phone: (301) 443-2114; or the DGM main line (301) 443-5204, Fax: (301) 594-0899, Email: [email protected]. VIII. Other Information The Public Health Service strongly encourages all cooperative agreement and contract recipients to provide a [[Page 40540]] smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of the facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the HHS mission to protect and advance the physical and mental health of the American people. Dated: August 10, 2018. Michael D. Weahkee, RADM, Assistant Surgeon General, U.S. Public Health Service, Acting Director, Indian Health Service. [FR Doc. 2018-17564 Filed 8-14-18; 8:45 am] BILLING CODE 4165-16-P
![40532 Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices
eligible for benefits and services from violations potentially affecting the and contract recipients to provide a
the IHS. Federal award. 45 CFR 75.113. smoke-free workplace and promote the
Recipients will be required to sign the Disclosures must be sent in writing to: non-use of all tobacco products. In
HHS–690 Assurance of Compliance U.S. Department of Health and Human addition, Public Law 103–227, the Pro-
form which can be obtained from the Services, Indian Health Service, Children Act of 1994, prohibits smoking
following website: http://www.hhs.gov/ Division of Grants Management, ATTN: in certain facilities (or in some cases,
sites/default/files/forms/hhs-690.pdf, Robert Tarwater, Director, 5600 Fishers any portion of the facility) in which
and send it directly to the: U.S. Lane, Mail Stop: 09E70, Rockville, MD regular or routine education, library,
Department of Health and Human 20857. day care, health care, or early childhood
Services, Office of Civil Rights, 200 (Include ‘‘Mandatory Grant development services are provided to
Independence Ave. SW, Washington, Disclosures’’ in subject line) children. This is consistent with the
DC 20201. Office: (301) 443–5204. HHS mission to protect and advance the
Fax: (301) 594–0899. physical and mental health of the
E. Federal Awardee Performance and
Email: Robert.Tarwater@ihs.gov. American people.
Integrity Information System (FAPIIS)
The IHS is required to review and AND Dated: August 9, 2018.
consider any information about the U.S. Department of Health and Michael D. Weahkee,
applicant that is in the Federal Awardee Human Services, Office of Inspector Assistant Surgeon General, U.S. Public Health
Performance and Integrity Information General, ATTN: Mandatory Grant Service, Acting Director, Indian Health
System (FAPIIS) before making any Disclosures, Intake Coordinator, 330 Service.
award in excess of the simplified Independence Avenue SW, Cohen [FR Doc. 2018–17515 Filed 8–14–18; 8:45 am]
acquisition threshold (currently Building, Room 5527, Washington, DC BILLING CODE 4165–16–P
$150,000) over the period of 20201, URL: http://oig.hhs.gov/fraud/
performance. An applicant may review report-fraud/index.asp.
and comment on any information about (Include ‘‘Mandatory Grant DEPARTMENT OF HEALTH AND
itself that a Federal awarding agency Disclosures’’ in subject line) HUMAN SERVICES
previously entered. IHS will consider Fax: (202) 205–0604 (Include
Indian Health Service
any comments by the applicant, in ‘‘Mandatory Grant Disclosures’’ in
addition to other information in FAPIIS subject line) or Division of Epidemiology and Disease
in making a judgment about the Email: Prevention; Epidemiology Program for
applicant’s integrity, business ethics, MandatoryGranteeDisclosures@ American Indian/Alaska Native Tribes
and record of performance under oig.hhs.gov. and Urban Indian Communities
Federal awards when completing the Failure to make required disclosures
review of risk posed by applicants as can result in any of the remedies Announcement Type: Competing
described in 45 CFR 75.205. described in 45 CFR 75.371. Remedies Supplement
As required by 45 CFR part 75 for noncompliance, including Funding Announcement Number: HHS–
Appendix XII of the Uniform Guidance, suspension or debarment (See 2 CFR 2018–IHS–EPI–0001
non-federal entities (NFEs) are required parts 180 and 376 and 31 U.S.C. 3321). Catalog of Federal Domestic Assistance
to disclose in FAPIIS any information Number: 93.231
VII. Agency Contacts
about criminal, civil, and administrative Key Dates
proceedings, and/or affirm that there is 1. Questions on the programmatic
no new information to provide. This issues may be directed to: Lisa C. Neel, Application Deadline Date: September
applies to NFEs that receive Federal Public Health Advisor, Office of Public 12, 2018
Health Support, Division of Review Date: September 14–18, 2018
awards (currently active grants, Earliest Anticipated Start Date:
cooperative agreements, and Epidemiology & Disease Prevention,
September 30, 2018
procurement contracts) greater than Indian Health Service, 5600 Fishers
$10,000,000 for any period of time Lane, Mailstop: 09E17B, Rockville, MD I. Funding Opportunity Description
during the period of performance of an 20857, Phone: (301) 443–4305, EMail:
Statutory Authority
award/project. Lisa.Neel@ihs.gov.
2. Questions on grants management The Indian Health Service (IHS)
Mandatory Disclosure Requirements and fiscal matters may be directed to: Office of Public Health Support,
As required by 2 CFR part 200 of the John Hoffman, Senior Grants Division of Epidemiology and Disease
Uniform Guidance, and the HHS Management Specialist, 5600 Fishers Prevention (DEDP), is accepting
implementing regulations at 45 CFR part Lane, Mail Stop: 09E70, Rockville, MD applications for cooperative agreement
75, effective January 1, 2016, the IHS 20857, Phone: (301) 443–2116, Fax: for competitive supplemental funds to
must require a non-Federal entity or an (301) 594–0899, Email: John.Hoffman@ enhance activities in the Epidemiology
applicant for a Federal award to ihs.gov. Program for American Indian/Alaska
disclose, in a timely manner, in writing 3. Questions on systems matters may Native (AI/AN) Tribes and Urban Indian
to the IHS or pass-through entity all be directed to: Paul Gettys, Grant communities. This program is
violations of Federal criminal law Systems Coordinator, 5600 Fishers authorized under: Section 317(k)(2) of
involving fraud, bribery, or gratuity Lane, Mail Stop: 09E70, Rockville, MD the Public Health Service Act (42 U.S.C.
violations potentially affecting the 20857, Phone: (301) 443–2114; or the Section 247b(k)), as amended. Funding
daltland on DSKBBV9HB2PROD with NOTICES
Federal award. DGM main line (301) 443–5204, Fax: for this award will be provided by: The
Submission is required for all (301) 594–0899, EMail: Paul.Gettys@ Centers for Disease Control and
applicants and recipients, in writing, to ihs.gov. Prevention’s (CDC) National Center for
the IHS and to the HHS Office of Chronic Disease Prevention and Health
Inspector General all information VIII. Other Information Promotion. The authorities will be
related to violations of Federal criminal The Public Health Service strongly exercised by CDC and through an Intra-
law involving fraud, bribery, or gratuity encourages all cooperative agreement Departmental Delegation of Authority
VerDate Sep<11>2014 18:28 Aug 14, 2018 Jkt 244001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1](https://thefederalregister.org/doc/83_FR_40690/page/1.svg)
![Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 40533
(IDDA) with IHS to create a Center for Chronic Disease Prevention the Gathering of Native Americans
supplemental funding opportunity for and Health Promotion, the Division of (GONA) teaching methods.
Tribal Epidemiology Centers. The Cancer Prevention and Control (DCPC)
Limited Competition Justification
administration will be carried out works with national organizations, state
through an Intra-agency Agreement and Tribal health agencies, and other The IHS enters into cooperative
(IAA) between CDC and IHS. This key groups to develop, implement, and agreements with TECs under the
program is described in the Catalog of promote effective strategies for authority of Section 214(a)(1) of the
Federal Domestic Assistance (CFDA) preventing and controlling cancer. Indian Health Care Improvement Act,
under 93.231. Public Law 94–437, as amended by
Purpose Public Law 102–573. Tribal
Background The National Center for Chronic Epidemiology Centers carry out a list of
The Tribal Epidemiology Center (TEC) Disease Prevention and Health functions specified in statute. These
program was authorized by Congress in Promotion will be supporting two functions include data collection and
1998 as a way to provide public health activities with funding from DCPC. The analysis; evaluation of existing delivery
support to multiple Tribes and Urban first, Colorectal Cancer Screening systems, data systems, and other
Indian communities in each of the IHS Among AI/AN with Diabetes, seeks to systems that impact the improvement of
Areas. Only current TEC grantees are reduce a diabetes-linked cancer health Indian health; making recommendations
eligible to apply for the competing disparity experienced by the AI/AN for the targeting of services; and
supplemental funding under this population. This population provision of requested technical
announcement and must demonstrate experiences the highest rates of diabetes assistance to Indian Tribes, Tribal
that they have complied with previous in the United States. Despite the recent organizations, and Urban Indian
terms and conditions of the TEC identification of diabetes as a significant organizations [25 U.S.C. 1621m(b)].
program. risk factor for colorectal cancer (CRC), Other organizations do not have the
TECs are uniquely positioned within screening rates remain poor in the capacity to provide this support. With
Tribes, Tribal and Urban Indian diabetic population. Consequently, respect to access to information, TECs
organizations to conduct disease there is a critical need for effective are treated as public health authorities
surveillance, research, prevention and intervention that promotes both CRC for the purposes of the Health Insurance
control of disease, injury, or disability, risk awareness and screening among AI/ Portability and Accountability Act of
and to assess the effectiveness of AI/AN ANs with diabetes. 1996 (Pub L. 104–191). Unlike their
public health programs. Positioned The second National Center for counterparts, they have no (or little)
uniquely within Tribes and Tribal or Chronic Disease Prevention and Health funding from their jurisdictional
Urban Organizations, TECs are able to Promotion activity, Annual Cancer governments to perform these public
conduct disease surveillance, research, Survivorship Group Leadership functions.
prevention and control of disease, Training, seeks to increase cancer The IHS and the CDC have
injury, or disability. This allows them to survivor support group leadership in determined that the TECs provide the
assess the effectiveness of AI/AN public AI/AN communities. most effective approach to strengthen
health programs. In addition, they can This cooperative agreement is to public health capacity to support Tribes,
fill gaps in data needed for the relevant support the following National Center Tribal organizations, and Urban Indian
Government Performance and Results for Chronic Disease Prevention and organizations, in identifying relevant
Act and Healthy People 2020 measures. Health Promotion activities: health status indicators and priorities
Some of the existing TECs have already (a) Colorectal Cancer Screening using sound epidemiologic principles.
developed innovative strategies to Among AI/AN with Diabetes.
monitor the health status of Tribes and i. Develop a culturally grounded, II. Award Information
Urban Indian communities, including multilevel intervention to communicate
the development of Tribal health Type of Award
CRC risk and prevention information to
registries and use of sophisticated AI/AN men and women over age 50 Cooperative Agreement.
record linkage computer software to who have diabetes. Estimated Funds Available
correct existing state data sets for racial ii. Determine effectiveness of
misclassification. Tribal Epidemiology colorectal cancer screening through The total amount of funding
Centers work in partnership with IHS direct mailing fecal immunochemical identified for the current fiscal year (FY)
DEDP to provide a more accurate test (FIT) kits to AI/AN patients with 2018 is approximately $220,000. An
national picture of Indian health status. diabetes. estimated $135,000 will be awarded for
To further the goals of the partnership, iii. Develop a plan to embed CRC the National Center for Chronic Disease
a new CDC funding opportunity will be control initiatives within established Prevention and Health Promotion
made available to TECs to implement diabetes management systems at Indian Colorectal Cancer Screening Among
cancer projects in Indian Country, Health Service/Tribal health facilities. American Indians with Diabetes
designed to help decrease these (b) Annual Cancer Survivorship activities, and, a total of $85,000 will be
disparities and lessen the burden of Leadership Training. awarded for the National Center for
cancer in this population. For i. Organize and implement at least Chronic Disease Prevention and Health
administrative purposes, this new two, three-day cancer support Promotion Annual Cancer Survivorship
funding opportunity will be packaged leadership trainings for 15–25 AI/AN Group Leadership Trainings. Individual
with the existing IHS cooperative participants, nationally. The training award amounts are anticipated to be
daltland on DSKBBV9HB2PROD with NOTICES
agreements. will be designed to give participants a between $85,000 and $220,000. The
The mission of the CDC National unique opportunity to work together in amount of funding available for
Center for Chronic Disease Prevention a safe, supportive environment to learn competing and continuation awards
and Health Promotion is to help people and practice skills to help people issued under this announcement are
and communities prevent chronic affected by cancer in their communities. subject to the availability of
diseases and promote health and The training will be based on the model, appropriations and budgetary priorities
wellness for all. Within the National A Gathering of Cancer Support, using of the CDC. The IHS is under no
VerDate Sep<11>2014 18:28 Aug 14, 2018 Jkt 244001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1](https://thefederalregister.org/doc/83_FR_40690/page/2.svg)
![40540 Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices
smoke-free workplace and promote the Dated: August 9, 2018. and Transplantation Research; 93.856,
non-use of all tobacco products. In Melanie J. Pantoja, Microbiology and Infectious Diseases
addition, Public Law 103–227, the Pro- Program Analyst, Office of Federal Advisory Research, National Institutes of Health, HHS)
Children Act of 1994, prohibits smoking Committee Policy.
Dated: August 9, 2018.
in certain facilities (or in some cases, [FR Doc. 2018–17474 Filed 8–14–18; 8:45 am]
Natasha M. Copeland,
any portion of the facility) in which BILLING CODE 4140–01–P
Program Analyst, Office of Federal Advisory
regular or routine education, library, Committee Policy.
day care, health care, or early childhood [FR Doc. 2018–17477 Filed 8–14–18; 8:45 am]
development services are provided to DEPARTMENT OF HEALTH AND
children. This is consistent with the HUMAN SERVICES BILLING CODE 4140–01–P
HHS mission to protect and advance the National Institutes of Health
physical and mental health of the DEPARTMENT OF HEALTH AND
American people. National Institute of Allergy and HUMAN SERVICES
Dated: August 10, 2018. Infectious Diseases; Notice of Closed
Meetings National Institutes of Health
Michael D. Weahkee,
RADM, Assistant Surgeon General, U.S. Pursuant to section 10(d) of the Center for Scientific Review; Notice of
Public Health Service, Acting Director, Indian Federal Advisory Committee Act, as Closed Meeting
Health Service. amended, notice is hereby given of the
[FR Doc. 2018–17564 Filed 8–14–18; 8:45 am] following meetings. Pursuant to section 10(d) of the
BILLING CODE 4165–16–P The meetings will be closed to the Federal Advisory Committee Act, as
public in accordance with the amended, notice is hereby given of the
provisions set forth in sections following meeting.
DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., The meeting will be closed to the
HUMAN SERVICES as amended. The grant applications and public in accordance with the
the discussions could disclose provisions set forth in sections
National Institutes of Health confidential trade secrets or commercial 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
property such as patentable material, as amended. The grant applications and
National Institute of Mental Health; and personal information concerning the discussions could disclose
Notice of Closed Meeting individuals associated with the grant confidential trade secrets or commercial
applications, the disclosure of which property such as patentable material,
Pursuant to section 10(d) of the would constitute a clearly unwarranted and personal information concerning
Federal Advisory Committee Act, as invasion of personal privacy. individuals associated with the grant
amended, notice is hereby given of the Name of Committee: National Institute of applications, the disclosure of which
following meeting. Allergy and Infectious Diseases Special would constitute a clearly unwarranted
The meeting will be closed to the Emphasis Panel NIAID; Clinical Trial invasion of personal privacy.
public in accordance with the Planning Grant (R34).
Date: September 5, 2018. Name of Committee: Center for Scientific
provisions set forth in sections Time: 10:00 a.m. to 11:30 a.m. Review Special Emphasis Panel; Special
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: To review and evaluate grant Topic in Nephrology.
as amended. The grant applications and applications. Date: August 22, 2018.
the discussions could disclose Place: National Institutes of Health, 5601 Time: 2:00 p.m. to 4:00 p.m.
confidential trade secrets or commercial Fishers Lane, Rockville, MD 20892. Agenda: To review and evaluate grant
property such as patentable material, (Telephone Conference Call). applications.
Contact Person: Ellen S. Buczko, Ph.D., Place: National Institutes of Health, 6701
and personal information concerning Rockledge Drive, Bethesda, MD 20892,
Scientific Review Officer, Scientific Review
individuals associated with the grant Program, Division of Extramural Activities, (Telephone Conference Call).
applications, the disclosure of which Room # 3F30A, National Institutes of Health/ Contact Person: Atul Sahai, Ph.D.,
would constitute a clearly unwarranted NIAID, 5601 Fishers Lane, MSC 9823, Scientific Review Officer, Center for
invasion of personal privacy. Bethesda, MD 20892–9823, (240) 669–5028, Scientific Review, National Institutes of
ebuczko1@niaid.nih.gov. Health, 6701 Rockledge Drive, Room 2188,
Name of Committee: National Institute of
Name of Committee: National Institute of MSC 7818, Bethesda, MD 20892, 301–435–
Mental Health Initial Review Group; Mental 1198, sahaia@csr.nih.gov.
Allergy and Infectious Diseases Special
Health Services Research Committee. Emphasis Panel NIAID; Clinical Trial This notice is being published less than 15
Date: October 15, 2018. Planning Grant (R34). days prior to the meeting due to the timing
Time: 8:00 a.m. to 5:00 p.m. Date: September 5, 2018. limitations imposed by the review and
Agenda: To review and evaluate grant Time: 1:00 p.m. to 2:30 p.m. funding cycle.
applications. Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance
Place: The Fairmont Washington, DC, 2401 applications. Program Nos. 93.306, Comparative Medicine;
M Street NW, Washington, DC 20037. Place: National Institutes of Health, 5601 93.333, Clinical Research, 93.306, 93.333,
Contact Person: Aileen Schulte, Ph.D., Fishers Lane, Rockville, MD 20892, 93.337, 93.393–93.396, 93.837–93.844,
Scientific Review Officer, Division of (Telephone Conference Call). 93.846–93.878, 93.892, 93.893, National
Extramural Activities, National Institute of Contact Person: Ellen S. Buczko, Ph.D., Institutes of Health, HHS)
daltland on DSKBBV9HB2PROD with NOTICES
Scientific Review Officer, Scientific Review
Mental Health, NIH, Neuroscience Center,
Program, Division of Extramural Activities, Dated: August 9, 2018.
6001 Executive Blvd., Room 6136, MSC 9606,
Room # 3F30A, National Institutes of Health/
Bethesda, MD 20852, 301–443–1225, Natasha M. Copeland,
NIAID, 5601 Fishers Lane, MSC 9823,
aschulte@mail.nih.gov. Bethesda, MD 20892–9823, (240) 669–5028, Program Analyst, Office of Federal Advisory
(Catalogue of Federal Domestic Assistance ebuczko1@niaid.nih.gov. Committee Policy.
Program No. 93.242, Mental Health Research (Catalogue of Federal Domestic Assistance [FR Doc. 2018–17472 Filed 8–14–18; 8:45 am]
Grants, National Institutes of Health, HHS) Program Nos. 93.855, Allergy, Immunology, BILLING CODE 4140–01–P
VerDate Sep<11>2014 18:28 Aug 14, 2018 Jkt 244001 PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 E:\FR\FM\15AUN1.SGM 15AUN1](https://thefederalregister.org/doc/83_FR_40690/page/9.svg)
Document Created: 2018-08-15 01:26:42
Document Modified: 2018-08-15 01:26:42
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | September 12, 2018 Review Date: September 14-18, 2018 Earliest Anticipated Start Date: September 30, 2018 | |
| FR Citation | 83 FR 40532 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR